Investor information
Cash distributions per share
| Year | Amount in CHF | Ex-date | Payment date |
|---|---|---|---|
| 2022 | 9.70 | 30.08.2022 | 01.09.2022 |
| 2021 | 3.00 9.50 |
07.09.2021 07.09.2021 |
09.09.2021 Anniversary Payment 09.09.2021 Ordinary Distribution |
| 2020 | 7.70 | 08.09.2020 | 10.09.2020 |
| 2019 | 7.50 | 10.09.2019 | 12.09.2019 |
| 2018 | 5.50 1.50 |
27.06.2018 19.09.2018 |
29.06.2018 21.09.2018 |
| 2017 | 5.80 | 28.06.2017 | 30.06.2017 |
| 2016 | 5.50 | 28.06.2016 | 30.06.2016 |
| 2015 | 5.50 | 01.07.2015 | 06.07.2015 |
| 2014 | 3.00 | 24.06.2014 | 27.06.2014 |
| 2013 | 1.50 | 04.09.2013 | 09.09.2013 |
Significant shareholders
Based on the notifications received by the Company, the following shareholders reported equity holdings in HBM Healthcare Investments Ltd of three percent or more:
| Shareholding | Shareholder |
|---|---|
| 15 - 20% | Nogra Pharma Invest S.à.r.l., Luxemburg |
See here for details about significant shareholders in HBM Healthcare Investments Ltd. (SIX Swiss Exchange).
Fees
Management fees (paid quarterly):
0.75% of company assets plus
0.75% of the company's market capitalisation
Performance fee (paid annually):
15% on increase in value above the high water mark. High water mark (per share for all outstanding shares) for financial year 2021/2022: NAV of CHF 315.27.
Presentations
HBM Healthcare Investments Company Presentation
HBM Healthcare Investments Factsheet
HBM Healthcare Investments Key Investor Information
Analyst reports
Berenberg Investment Companies June 2022
Kepler Cheuvreux Report May 2022
Kepler Cheuvreux Report April 2022
Kepler Cheuvreux Report October 2021
Kepler Cheuvreux Report July 2021
Kepler Cheuvreux Report April 2021
Kepler Cheuvreux Report January 2021
Management transactions
See here for details about Management transactions in HBM Healthcare Investments' shares (SIX Swiss Exchange).
Articles of association
Articles of Association of HBM Healthcare Investments Ltd.
Share buy-back programmes
Share buy-back programme 2022
The maximum permissible daily repurchase volume in accordance with Art. 123 para. 1 lit. (c) FinfraV amounts to 1'047 shares.
HBM Healthcare Investments launches a new share buy-back programme
Rückkauf eigener Aktien zum Zweck der Kapitalherabsetzung (German)
Rachat d’actions propres dans le but d’une réduction de capital (French)
Share buy-back programme 2019-2022 (terminated)
The maximum permissible daily repurchase volume in accordance with Art. 123 para. 1 lit. (c) FinfraV amounts to 1'203 shares.